Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA)

Emily A. Verbus; Alexander J. Rossi; Allen J. Luna; Atif Iqbal; Van K. Morris; Jonathan M. Hernandez

doi:10.1245/s10434-021-10112-z

Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA)

Emily A. Verbus, Alexander J. Rossi, Allen J. Luna, Atif Iqbal, Van K. Morris, Jonathan M. Hernandez

GI Medical Oncology

Research output: Contribution to journal › Comment/debate › peer-review

8 Scopus citations

Original language	English (US)
Pages (from-to)	4095-4097
Number of pages	3
Journal	Annals of surgical oncology
Volume	28
Issue number	8
DOIs	https://doi.org/10.1245/s10434-021-10112-z
State	Published - Aug 2021

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1245/s10434-021-10112-z

Cite this

@article{69e88cfae8b143bbb365388a712bd476,

title = "Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA)",

author = "Verbus, {Emily A.} and Rossi, {Alexander J.} and Luna, {Allen J.} and Atif Iqbal and Morris, {Van K.} and Hernandez, {Jonathan M.}",

note = "Funding Information: Research funding was provided to MD Anderson by BioNtech AG, Boehringer Ingelheim, Bristol Myers Squibb, EMD Serono, Immatics, and Pfizer.",

year = "2021",

month = aug,

doi = "10.1245/s10434-021-10112-z",

language = "English (US)",

volume = "28",

pages = "4095--4097",

journal = "Annals of surgical oncology",

issn = "1068-9265",

publisher = "Springer New York",

number = "8",

}

TY - JOUR

T1 - Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA)

AU - Verbus, Emily A.

AU - Rossi, Alexander J.

AU - Luna, Allen J.

AU - Iqbal, Atif

AU - Morris, Van K.

AU - Hernandez, Jonathan M.

N1 - Funding Information: Research funding was provided to MD Anderson by BioNtech AG, Boehringer Ingelheim, Bristol Myers Squibb, EMD Serono, Immatics, and Pfizer.

PY - 2021/8

Y1 - 2021/8

UR - http://www.scopus.com/inward/record.url?scp=85105891117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85105891117&partnerID=8YFLogxK

U2 - 10.1245/s10434-021-10112-z

DO - 10.1245/s10434-021-10112-z

M3 - Comment/debate

C2 - 33999346

AN - SCOPUS:85105891117

SN - 1068-9265

VL - 28

SP - 4095

EP - 4097

JO - Annals of surgical oncology

JF - Annals of surgical oncology

IS - 8

ER -

Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this